AKORN INC FDA Approval ANDA 077764

ANDA 077764

AKORN INC

FDA Drug Application

Application #077764

Documents

Letter2009-03-17

Application Sponsors

ANDA 077764AKORN INC

Marketing Status

Prescription001

Application Products

001SOLUTION/DROPS;OPHTHALMICEQ 0.5% BASE0APRACLONIDINE HYDROCHLORIDEAPRACLONIDINE HYDROCHLORIDE

FDA Submissions

ORIG1AP2009-03-12
LABELING; LabelingSUPPL2AP2022-09-28STANDARD

Submissions Property Types

SUPPL1Null15
SUPPL2Null7

TE Codes

001PrescriptionAT

CDER Filings

AKORN INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 77764
            [companyName] => AKORN INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"APRACLONIDINE HYDROCHLORIDE","activeIngredients":"APRACLONIDINE HYDROCHLORIDE","strength":"EQ 0.5% BASE","dosageForm":"SOLUTION\/DROPS;OPHTHALMIC","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"APRACLONIDINE HYDROCHLORIDE","submission":"APRACLONIDINE HYDROCHLORIDE","actionType":"EQ 0.5% BASE","submissionClassification":"SOLUTION\/DROPS;OPHTHALMIC","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.